| domain | amgeniss.com |
| summary | Here’s a summary of the website content:
This research collaboration with Amgen focuses on investigating inebilizumab’s potential in neuromyelitis optica spectrum disorder (NMOSD) and other autoimmune conditions. Key obligations include adhering to Good Clinical Practice and safety reporting regulations, maintaining necessary clinical trial authorizations, providing regular safety reports and study updates, submitting final reports and manuscripts, and exploring biomarkers, clinical outcomes, patient-reported outcomes, and real-world evidence related to inebilizumab’s effectiveness and application across diverse populations, including specific demographic groups and older adults. |
| title | ISS home page |
| description | ISS home page |
| keywords | research, areas, interest, product, studies, disease, treatment, safety, proposal, patient, novel, agreement, review, study, here, sponsor, start |
| upstreams |
|
| downstreams |
|
| nslookup | A 35.155.101.154, A 34.210.188.219, A 34.213.167.15 |
| created | 2025-05-17 |
| updated | 2026-02-02 |
| summarized | 2026-02-03 |
|
|